Pharmacovigilance – Products

Thermo Fisher Scientific has introduced the enhanced Thermo Scientific™ Vanquish™ Charged Aerosol Detector (CAD) P Series, an innovation to improve the analysis of the most complex samples, even those with analytes that do not possess chromophores.

CN Bio introduces new animal MPS models to improve drug safety and predict human toxicity in preclinical drug testing.

DEBRA Research and Dermaliq partner to advance cutaneous drug delivery for improved wound healing and therapies in EB.

Thermo Fisher introduces next-gen mass spectrometry solutions at ASMS, designed to accelerate research in multiple scientific fields.

CN Bio partners with SCINCO to expand its reach in South Korea, enhancing access to its FDA-recognized PhysioMimix® Organ-on-a-chip systems.

MitoRx’s Myo4 reduces weight and fat mass while preserving muscle and bone in an obesity mouse model.

Bionova licenses ATUM’s Leap-In tech to speed up cell line development and streamline biologics manufacturing.

Waters Corporation has announced that its Empower™ Software now supports biologics data acquisition and quality control (QC) analysis from Multi-Angle Light Scattering (MALS) and differential Refractive Index (RI) instruments in its Wyatt Technology™

PGxAI's Deneb model uses AI and multi-omics data to predict patient drug responses, streamlining drug development and reducing trial failures.

Signals One spans the entire “Design-Make-Test-Decide” R&D lifecycle and empowers researchers to address previously “undruggable” targets.